LIVERPOOL CHIROCHEM LIMITED
LIVERPOOL CHIROCHEM LIMITED
Company No:
LIVERPOOL CHIROCHEM LIMITED
Unaudited Financial Statements
For the financial year ended 31 December 2021
Pages for filing with the registrar
For the financial year ended 31 December 2021
Pages for filing with the registrar
Unaudited Financial Statements
Contents
COMPANY INFORMATION
COMPANY INFORMATION (continued)
DIRECTORS | P Colbon |
S Noble | |
A Round | |
M Stewart |
SECRETARY | P Colbon |
REGISTERED OFFICE | 48-52 Penny Lane |
Mossley Hill | |
Liverpool | |
L18 1DG | |
United Kingdom |
COMPANY NUMBER | 08900140 (England and Wales) |
CHARTERED ACCOUNTANTS | Hurst Accountants Ltd |
Lancashire Gate | |
21 Tiviot Dale | |
Stockport | |
SK1 1TD |
BALANCE SHEET
BALANCE SHEET (continued)
Note | 2021 | 2020 | ||
£ | £ | |||
Fixed assets | ||||
Intangible assets | 3 |
|
|
|
Tangible assets | 4 |
|
|
|
Investments | 5 |
|
|
|
3,158,833 | 3,296,574 | |||
Current assets | ||||
Stocks | 6 |
|
|
|
Debtors | 7 |
|
|
|
Cash at bank and in hand |
|
|
||
3,451,229 | 845,370 | |||
Creditors | ||||
Amounts falling due within one year | 8 | (
|
(
|
|
Net current (liabilities)/assets | (79,936) | 317,071 | ||
Total assets less current liabilities | 3,078,897 | 3,613,645 | ||
Creditors | ||||
Amounts falling due after more than one year | 9 | (
|
|
|
Net assets |
|
|
||
Capital and reserves | ||||
Called-up share capital | 11 |
|
|
|
Share premium account |
|
|
||
Profit and loss account | (
|
(
|
||
Total shareholders' funds |
|
|
Directors' responsibilities:
-
The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476; -
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and -
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.
The financial statements of Liverpool Chirochem Limited (registered number:
S Noble
Director |
NOTES TO THE FINANCIAL STATEMENTS
NOTES TO THE FINANCIAL STATEMENTS
1. Accounting policies
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
General information and basis of accounting
Liverpool Chirochem Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 48-52 Penny Lane, Mossley Hill, Liverpool, L18 1DG, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the company and rounded to the nearest £.
Going concern
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors note that the business has net current liabilities of £79,936 (2020: £317,071 net current assets). The Company is supported through loans from the shareholders and the future fund. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the shareholders will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Foreign currency
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.
Interest income
Employee benefits
Defined contribution schemes
The Company operates a defined contribution scheme. The amount charged to the Statement of Income and Retained Earnings in respect of pension costs and other post-retirement benefits is the contributions payable in the financial year. Differences between contributions payable in the financial year and contributions actually paid are included within other creditors in the Balance Sheet.
Finance costs
Finance costs are charged to the Statement of Income and Retained Earnings over the term of the debt using the effective interest method so the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Taxation
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.
Revenue
Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Revenue from the sale of good is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on delivery to the customer), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the cost incurred or to be incurred in respect of the transaction can be measured reliably.
Research and development
In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.
Intangible assets
Trademarks, patents and licences |
|
Tangible fixed assets
Plant and machinery |
|
Office equipment |
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Leases
Assets held under finance leases, hire purchase contracts and other similar arrangements, which confer rights and obligations similar to those attached to owned assets, are capitalised as tangible fixed assets at the fair value of the leased asset (or, if lower, the present value of the minimum lease payments as determined at the inception of the lease) and are depreciated over the shorter of the lease terms and their useful lives. The capital elements of future lease obligations are recorded as liabilities, while the interest elements are charged to the Statement of Income and Retained Earnings over the period of the leases to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals under operating leases are charged on a straight-line basis over the lease term, even if the payments are not made on such a basis. Benefits received and receivable as an incentive to sign an operating lease are similarly spread on a straight-line basis over the lease term.
Impairment of assets
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Stocks
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Trade and other debtors
Cash and cash equivalents
Trade and other creditors
Financial instruments
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or income as appropriate. The company does not currently apply hedge accounting for interest rate and foreign exchange derivatives.
The company has chosen to adopt Sections 11 and 12 of FRS 102 in respect of financial instruments. Financial liabilities and equity instruments are classified according to the substance of the contractual arrangement entered into.
A financial liability exists where there is a contractual obligation to deliver cash or another financial asset to another entity, or to exchange financial assets or financial liabilities under potentially unfavourable conditions.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.
Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings.
For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.
For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.
Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or income as appropriate. The company does not currently apply hedge accounting for interest rate and foreign exchange derivatives.
Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.
Provisions
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.
2. Employees
2021 | 2020 | ||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including directors |
|
|
3. Intangible assets
Trademarks, patents and licences |
Total | ||
£ | £ | ||
Cost | |||
At 01 January 2021 |
|
|
|
Additions |
|
|
|
At 31 December 2021 |
|
|
|
Accumulated amortisation | |||
At 01 January 2021 |
|
|
|
Charge for the financial year |
|
|
|
At 31 December 2021 |
|
|
|
Net book value | |||
At 31 December 2021 |
|
|
|
At 31 December 2020 |
|
|
4. Tangible assets
Plant and machinery | Office equipment | Total | |||
£ | £ | £ | |||
Cost | |||||
At 01 January 2021 |
|
|
|
||
Additions |
|
|
|
||
Disposals | (
|
|
(
|
||
At 31 December 2021 |
|
|
|
||
Accumulated depreciation | |||||
At 01 January 2021 |
|
|
|
||
Charge for the financial year |
|
|
|
||
Disposals | (
|
|
(
|
||
At 31 December 2021 |
|
|
|
||
Net book value | |||||
At 31 December 2021 |
|
|
|
||
At 31 December 2020 |
|
|
|
5. Fixed asset investments
Other investments | Total | ||
£ | £ | ||
Carrying value before impairment | |||
At 01 January 2021 |
|
|
|
Movement on investment for trade | (
|
(
|
|
At 31 December 2021 |
|
|
|
Provisions for impairment | |||
At 01 January 2021 |
|
|
|
At 31 December 2021 |
|
|
|
Carrying value at 31 December 2021 |
|
|
|
Carrying value at 31 December 2020 |
|
|
6. Stocks
2021 | 2020 | ||
£ | £ | ||
Stocks |
|
|
7. Debtors
2021 | 2020 | ||
£ | £ | ||
Trade debtors |
|
|
|
Other debtors |
|
|
|
|
|
8. Creditors: amounts falling due within one year
2021 | 2020 | ||
£ | £ | ||
Bank loans |
|
|
|
Trade creditors |
|
|
|
Other creditors |
|
|
|
Convertible loan notes |
|
|
|
Other taxation and social security |
|
|
|
Obligations under finance leases and hire purchase contracts (secured) |
|
|
|
|
|
Bank loans represent a loan from a provider which is accredited by the Government-owned British Business Bank to provide business loans under the Recovery Loan Scheme. The loan attracts interest of 5% per annum, is unsecured, and repayable monthly over a 5 year term.
Bank loan £50,000 in the prior year was previously included within other creditors.
9. Creditors: amounts falling due after more than one year
2021 | 2020 | ||
£ | £ | ||
Bank loans |
|
|
|
Obligations under finance leases and hire purchase contracts (secured) |
|
|
|
143,727 | 0 |
10. Convertible loans
The Company issued £2,000,000 of convertible loan notes. The convertible loan notes are convertible into ordinary shares of the Company at any time between the date of issue of the notes and their settlement date. The directors have exercised judgement in assessing the market rate of non-basic financial instruments held at fair value through the profit and loss. In the case of the loan notes, fair value has been assessed with reference to an estimated probability of the exercise of an option to convert the loan to equity.
11. Called-up share capital
2021 | 2020 | ||
£ | £ | ||
Allotted, called-up and fully-paid | |||
|
|
|
During the year 939,540 Ordinary shares were allotted with an aggregate nominal value of £940. Consideration for the allotted shares was £170,057, resulting in a share premium of £169,117.
12. Financial commitments
Pensions
The Company operates a defined contribution pension scheme for the directors and employees. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost expense represents contributions payable by the Company to the fund and amounted to £24,859 (2020 - £30,244).
2021 | 2020 | ||
£ | £ | ||
Unpaid contributions due to the fund (inc. in other creditors) |
|
|
13. Related party transactions
Transactions with the entity's directors
2021 | 2020 | ||
£ | £ | ||
Dr P Colbon | (2,625) | (2,625) | |
Dr R Ruan | 0 | (1,960) | |
Prof J Xiao | (3,290) | (3,290) |
The balances stated above are owed to the Directors at the balance sheet date and are included within other creditors. The balances do not attract interest.
14. Ultimate controlling party
By virtue of the share ownership split of the company, it is the opinion of the directors that there is no ultimate controlling party.